How to Read a Peptide COA: HPLC, LC-MS and Testing Limits
Learn how to read a peptide Certificate of Analysis, distinguish HPLC purity from LC-MS identity, match lots and spot what a report does not prove.
In brief
A useful peptide COA should identify the sample and lot, name the laboratory and methods, show interpretable results and link credibly to the material supplied. HPLC can estimate components and purity under a validated method; LC-MS can support molecular identity. Neither result alone proves sterility, endotoxin status, concentration accuracy, stability, clinical efficacy or human safety.
What is established—and what is not
- HPLC
- Separates and measures detected components under stated conditions
- LC-MS
- Supports identity through mass information and chromatographic context
- Sterility
- Requires a separate validated microbiological test
- Key uncertainty
- A polished PDF is only as credible as its sample chain and method
Five points to keep
- Match product, lot, strength and dates before reading the headline percentage.
- Purity and identity are different analytical questions.
- Ask who selected and sent the sample; chain of custody matters.
- Check whether raw chromatograms, acceptance criteria and method details are available.
- Do not infer sterility, dose, safety or efficacy from an HPLC result.
Start with document identity
Before interpreting a graph, verify the laboratory name and contact information, report number, sample name, batch or lot, date received, date tested and issuing date. The product and lot should match the item being evaluated. A certificate for a different strength, supplier or batch does not validate the material in front of you.
Look for signs that the report can be verified independently, such as a laboratory portal, report identifier or direct confirmation channel. A QR code is not proof by itself; it should resolve to a trustworthy record.
What HPLC purity means
High-performance liquid chromatography separates detected components based on their interaction with the analytical system. A reported area percentage often describes the main detected peak relative to other detected peaks under that method.
The number depends on sample preparation, detector response, integration, method suitability and what the method can detect. A 99% area result is not automatically 99% by mass, and it may not reveal every contaminant, solvent, salt, counter-ion or biological hazard.
What LC-MS contributes
Liquid chromatography–mass spectrometry can support identity by comparing observed mass information with the expected molecule while separating components. A strong report states the expected and observed values and describes the method sufficiently for interpretation.
Identity support and purity estimation complement each other. A dominant HPLC peak without adequate identity evidence could still represent the wrong substance; a matching mass signal does not by itself quantify every impurity.
Tests that answer different questions
Sterility, bacterial endotoxins, bioburden, residual solvents, water content, elemental impurities, concentration and stability require their own suitable methods. When a certificate says “pass,” find the method, specification and actual result rather than assuming a universal standard.
- Sterility: asks whether viable contaminating microorganisms are detected under a defined test.
- Endotoxin: evaluates bacterial endotoxin against a stated limit.
- Content or assay: estimates how much target material is present, which is not identical to chromatographic purity.
- Stability: requires time- and condition-specific data, not a one-time release test.
- Container integrity: concerns whether the package maintains protection over time.
Common COA red flags
Be cautious when a certificate lacks a lot number, uses a cropped chromatogram, reports only a percentage, omits the expected mass, has dates that predate the batch, or cannot be verified with the laboratory. Identical traces reused across unrelated products are another serious warning.
A seller-selected sample can also differ from routine inventory. Independent random sampling and a documented chain of custody provide stronger assurance than testing a hand-picked vial.
What a COA cannot tell a consumer
Even a genuine, technically sound COA does not authorize a product, establish an appropriate dose, predict benefit or prove human safety. It is one part of analytical quality evidence. Clinical and regulatory questions require separate evidence and professional oversight.
Common questions, careful answers
Is HPLC enough to identify a peptide?
Not reliably by itself. HPLC retention and peak shape can contribute information, while mass spectrometry or another orthogonal identity method strengthens identification.
Does 99% purity mean the vial is 99% peptide by weight?
Not necessarily. Many reports show chromatographic area percentage, which is method-dependent and not the same as total mass assay.
Does a COA prove sterility?
Only a separate, appropriate sterility test addresses that question, and its sampling and method still have limitations.
Evidence, standards and regulatory sources
- Q2(R2) Validation of Analytical Procedures ↗U.S. Food and Drug Administration
- IND chemistry, manufacturing and controls information ↗U.S. Food and Drug Administration
- USP harmonized sterility test standard ↗United States Pharmacopeia
- Pyrogen and endotoxins testing: questions and answers ↗U.S. Food and Drug Administration
Continue the evidence trail.
Related guides deepen the distinction between mechanism, analytical quality, approval and human evidence.